These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22527229)

  • 41. Cortical Hyperintensity on Diffusion-weighted Images as the Presymptomatic Marker of Sporadic Creutzfeldt-Jakob Disease.
    Maeda K; Sugihara Y; Shiraishi T; Hirai A; Satoh K
    Intern Med; 2019 Mar; 58(5):727-729. PubMed ID: 30333395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.
    Poser S; Mollenhauer B; Kraubeta A; Zerr I; Steinhoff BJ; Schroeter A; Finkenstaedt M; Schulz-Schaeffer WJ; Kretzschmar HA; Felgenhauer K
    Brain; 1999 Dec; 122 ( Pt 12)():2345-51. PubMed ID: 10581227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Patient with Creutzfeld-Jakob disease - a case report].
    Pastuszak Ż; Tomczykiewicz K; Stępień A; Piusińska-Macoch R; Klimczuk J; Rolewska A; Galbarczyk D
    Pol Merkur Lekarski; 2017 Feb; 42(248):84-86. PubMed ID: 28258683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creutzfeld-Jakob disease--reply.
    Angus-Leppan H; Rudge P; Mead S; Collinge J; Vincent A
    JAMA Neurol; 2013 Dec; 70(12):1589. PubMed ID: 24322520
    [No Abstract]   [Full Text] [Related]  

  • 45. VZV brainstem encephalitis triggers NMDA receptor immunoreaction.
    Schäbitz WR; Rogalewski A; Hagemeister C; Bien CG
    Neurology; 2014 Dec; 83(24):2309-11. PubMed ID: 25378669
    [No Abstract]   [Full Text] [Related]  

  • 46. Normalization of 14-3-3 in CJD.
    Schrooten M; De Vooght W; Weckhuysen S; Van Paesschen W; Van Damme P
    Acta Neurol Belg; 2008 Jun; 108(2):64-6. PubMed ID: 18795599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin 4 and interleukin 10 in Creutzfeldt-Jakob disease.
    Iwasaki Y; Baba S; Ikeda K
    Arch Neurol; 2006 Jun; 63(6):911; author reply 911. PubMed ID: 16769878
    [No Abstract]   [Full Text] [Related]  

  • 48. Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease.
    Salazar R
    Clin Neurol Neurosurg; 2018 May; 168():72-76. PubMed ID: 29525731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease.
    Takahashi H; Iwata T; Kitagawa Y; Takahashi RH; Sato Y; Wakabayashi H; Takashima M; Kido H; Nagashima K; Kenney K; Gibbs CJ; Kurata T
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):983-5. PubMed ID: 10548598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Creutzfeldt-Jakob disease: Report of one case].
    Ramírez M; Gallardo A; Vidal A; Cornejo S; Ramírez D; Medinas D; Bustamante G; Pasquali R; Hetz C
    Rev Med Chil; 2016 Jun; 144(6):796-806. PubMed ID: 27598501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 104 Cases.
    Qi C; Zhang JT; Zhao W; Xing XW; Yu SY
    Eur Neurol; 2020; 83(1):65-72. PubMed ID: 32344417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Creutzfeldt-Jakob Disease.
    Le VH
    J Am Osteopath Assoc; 2019 Jan; 119(1):63. PubMed ID: 30615045
    [No Abstract]   [Full Text] [Related]  

  • 53. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ; Knight RS; Macleod MA; Lowman A; Will RG
    Neurology; 2001 Apr; 56(7):986-7. PubMed ID: 11294951
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ
    Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and laboratory features of 14 young Chinese probable sCJD patients.
    Shi Q; Xiao K; Chen C; Zhou W; Gao C; Wang J; Zhang BY; Wang Y; Dong XP
    Prion; 2017 Mar; 11(2):128-135. PubMed ID: 28278113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient.
    Peoc'h K; Delasnerie-Lauprêtre N; Beaudry P; Laplanche JL
    Eur J Neurol; 2006 Apr; 13(4):427-8. PubMed ID: 16643327
    [No Abstract]   [Full Text] [Related]  

  • 57. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
    Aksamit AJ; Preissner CM; Homburger HA
    Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wernicke-Korsakoff syndrome as a rare phenotype of sporadic Creutzfeldt-Jakob disease.
    Bielewicz J; Szczepańska-Szerej A; Ogórek M; Dropko P; Wojtal K; Rejdak K
    Prion; 2018 Mar; 12(2):143-146. PubMed ID: 29380664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
    Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
    Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.